MARYAM AHMADIAN: Open Payments
NPI 1811909955 · BEVERLY HILLS, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$679 in 27 payments from 13 companies in 2025. Trend: 2023 $604 · 2024 $903 · 2025 $679
Food & beverage: $679
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation | 4 | $114 |
| Regeneron Healthcare Solutions, Inc. | 3 | $72 |
| GENZYME CORPORATION | 2 | $70 |
| Arcutis Biotherapeutics, Inc. | 3 | $62 |
| UCB, Inc. | 2 | $57 |
| Amgen Inc. | 3 | $53 |
| Journey Medical Corporation | 2 | $49 |
| Botanix SB Inc | 2 | $48 |
| PFIZER INC. | 2 | $42 |
| ABBVIE INC. | 1 | $35 |
Products named: DUPIXENT, OPZELURA, Zoryve, Bimzelx, OTEZLA, SOFDRA, CIBINQO, BOTOX.
Industry payments across CA — which companies pay providers there.
